Unknown

Dataset Information

0

Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials.


ABSTRACT: Antibiotic resistance poses rapidly increasing global problems in combatting multidrug-resistant (MDR) infectious diseases like MDR tuberculosis, prompting for novel approaches including host-directed therapies (HDT). Intracellular pathogens like Salmonellae and Mycobacterium tuberculosis (Mtb) exploit host pathways to survive. Only very few HDT compounds targeting host pathways are currently known. In a library of pharmacologically active compounds (LOPAC)-based drug-repurposing screen, we identify multiple compounds, which target receptor tyrosine kinases (RTKs) and inhibit intracellular Mtb and Salmonellae more potently than currently known HDT compounds. By developing a data-driven in silico model based on confirmed targets from public databases, we successfully predict additional efficacious HDT compounds. These compounds target host RTK signaling and inhibit intracellular (MDR) Mtb. A complementary human kinome siRNA screen independently confirms the role of RTK signaling and kinases (BLK, ABL1, and NTRK1) in host control of Mtb. These approaches validate RTK signaling as a drugable host pathway for HDT against intracellular bacteria.

SUBMITTER: Korbee CJ 

PROVIDER: S-EPMC5783939 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials.

Korbee Cornelis J CJ   Heemskerk Matthias T MT   Kocev Dragi D   van Strijen Elisabeth E   Rabiee Omid O   Franken Kees L M C KLMC   Wilson Louis L   Savage Nigel D L NDL   Džeroski Sašo S   Haks Mariëlle C MC   Ottenhoff Tom H M THM  

Nature communications 20180124 1


Antibiotic resistance poses rapidly increasing global problems in combatting multidrug-resistant (MDR) infectious diseases like MDR tuberculosis, prompting for novel approaches including host-directed therapies (HDT). Intracellular pathogens like Salmonellae and Mycobacterium tuberculosis (Mtb) exploit host pathways to survive. Only very few HDT compounds targeting host pathways are currently known. In a library of pharmacologically active compounds (LOPAC)-based drug-repurposing screen, we iden  ...[more]

Similar Datasets

| S-EPMC7195122 | biostudies-literature
| S-EPMC3997221 | biostudies-literature
2011-06-30 | E-GEOD-22272 | biostudies-arrayexpress
2011-06-30 | GSE22272 | GEO
| S-EPMC7903647 | biostudies-literature
| S-EPMC4987817 | biostudies-literature
| S-EPMC6133700 | biostudies-other
| S-EPMC7094952 | biostudies-literature
| S-EPMC2873204 | biostudies-literature
| S-EPMC6422095 | biostudies-literature